1. Home
  2. SCL vs IMTX Comparison

SCL vs IMTX Comparison

Compare SCL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stepan Company

SCL

Stepan Company

SELL

Current Price

$61.73

Market Cap

1.3B

ML Signal

SELL

IMTX

Immatics N.V.

HOLD

Current Price

$6.75

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCL
IMTX
Founded
1932
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SCL
IMTX
Price
$61.73
$6.75
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $17.26
AVG Volume (30 Days)
128.9K
★ 855.3K
Earning Date
10-28-2026
11-16-2026
Dividend Yield
★ 2.55%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,803,737,000.00
N/A
Revenue This Year
$8.56
N/A
Revenue Next Year
$5.92
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$41.82
$6.73
52 Week High
$68.00
$12.41

Technical Indicators

Market Signals
Indicator
SCL
IMTX
Relative Strength Index (RSI) 47.18 28.56
Support Level $60.06 N/A
Resistance Level $64.89 $10.08
Average True Range (ATR) 1.56 0.42
MACD -0.07 -0.08
Stochastic Oscillator 48.06 3.19

Price Performance

Historical Comparison
SCL
IMTX

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: